Contrary to the narrative of government inefficiency, Medicare's administrative overhead is only 2%. In contrast, private commercial insurers spend 16% of every dollar on administration, advertising, and claim disputes, revealing a major source of bloat in the US healthcare system.

Rising premiums and deductibles are pushing people away from traditional insurance. This isn't an abandonment of healthcare, but a market response to a product that no longer provides adequate value, forcing a shift towards cash-pay and alternative models.

While fee-for-service models incentivize in-clinic treatments, value-based care shifts the focus to outcomes and overall cost. Under these new models, home dialysis—which offers better patient outcomes and lower societal costs—becomes more profitable for providers, creating a powerful financial incentive to drive adoption.

Contrary to popular belief, Nordic countries are not socialist. They operate on a capitalist framework with private markets. Their extensive social safety nets are funded by extremely high taxes on everyone, including the middle and lower classes—a model fundamentally different from socialism's state ownership of production.

The choice between a competitive, market-based system and a European-style welfare state is not just economic. It's a choice between America's "hardcore" identity, which values risk-taking and innovation, and Europe's model of "managed decline," which prioritizes security over global influence and dynamism.

The idea of a single, equitable healthcare system is often a myth. Regardless of the official structure, a cash-pay system for faster or better care will almost always emerge for those who can afford it, a reality policymakers must acknowledge.

The immense regulatory complexity in U.S. healthcare creates an estimated $500 billion "tax" of administrative bloat. The non-obvious opportunity is that by using AI to eliminate this waste, the savings could be redirected to fund expanded patient care, rather than just being captured as profit.

Countries like Sweden and the Netherlands demonstrate that a nation can support a thriving innovation economy with billionaires and unicorns while also providing robust social safety nets like universal healthcare. This debunks the common American political argument that a country must choose between the two.

High healthcare costs are not an inherent failure of capitalism but a result of regulatory capture. Established companies influence legislation to create immense barriers to entry, stifling innovation from new competitors, which leads to ballooning administrative costs instead of more physicians and better care.